Verve Therapeutics Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2010
Period Ending	Aug '25 Aug 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '10 Dec 31, 2010
Market Capitalization	95,859	92,964	100,401	78,090	206,225
Market Cap Growth	-11.47%	-7.41%	28.57%	-62.13%	-
Enterprise Value	-2,785	-15,129	51,922	65,423	-
Last Close Price	2600.00	2500.00	2700.00	2100.00	10873.58
PE Ratio	-	-	11.72	-	7.09
PS Ratio	0.64	0.62	-	-	1.61
PB Ratio	0.42	0.40	0.41	0.33	0.52
P/TBV Ratio	0.42	0.40	0.41	0.33	0.52
P/FCF Ratio	-	-	4.53	-	-
P/OCF Ratio	-	-	4.44	56.81	-
EV/FCF Ratio	0.02	-	2.35	-	-
Debt / Equity Ratio	0	-	-	-	0.42
Asset Turnover	0.46	0.46	-	-	-
Inventory Turnover	137.65	137.65	4.07	-	-
Quick Ratio	3.58	4.05	0.51	1.20	1.85
Current Ratio	3.67	4.18	0.53	1.21	1.86
Return on Equity (ROE)	-7.24%	-5.98%	3.56%	-	-
Return on Assets (ROA)	-4.96%	-4.76%	-1.90%	-	-
Return on Capital (ROIC)	-6.87%	-6.60%	-3.13%	-	-
Earnings Yield	-17.98%	-15.29%	8.53%	-5.78%	14.10%
FCF Yield	-162.37%	-85.34%	22.05%	-0.79%	-
Buyback Yield / Dilution	-0.07%	-	0.29%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.